Optic zone diameter (OZD) refers to the width of the central vision-correcting area of a contact lens. This optical zone is designed to align with the pupil and provides refractive correction by focusing light onto the retina.

Although it is measured in millimetres like other contact lens parameters, optic zone diameter is not the same as the overall diameter of the lens. The overall diameter describes the full width of the lens from edge to edge, while the optic zone represents only the central corrective portion. The surrounding peripheral and transition areas contribute to lens fit and tear exchange beneath the lens.

In standard soft contact lenses, the optic zone diameter is built into the lens design by the manufacturer. It is relevant when selecting between lens designs for people with visual-quality concerns or when fitting specialist lenses. 

How Does Optic Zone Diameter Affect Vision?

The size of the optic zone influences how effectively a contact lens provides clear vision under different lighting conditions.

During the day or in brightly lit environments, the pupil becomes smaller. In these circumstances, a smaller optic zone is usually sufficient because the entire pupil remains within the corrective portion of the lens.

In darker settings, the pupil enlarges to allow more light into the eye. Younger individuals can experience pupil dilation of 7 mm or greater. If the pupil expands beyond the boundaries of the optic zone, some incoming light may pass through the lens’s peripheral regions rather than the central corrective area.

When this occurs, patients can experience visual disturbances such as:

• Halos around lights, particularly headlights and streetlights.
• Glare that reduces contrast and makes details more difficult to see.
• Ghosting, where faint duplicate images appear near the main image.

These effects are typically most noticeable at night and are more likely to affect individuals with larger pupils. In standard soft contact lenses, the manufacturer sets the optic zone diameter as part of the lens design. Differences between lens designs can influence visual performance, making optic zone diameter relevant when evaluating lens options for patients who report night-time visual symptoms.

How is Optic Zone Diameter Relevant to Specialist Lens Fitting?

In specialist contact lens practice, optic zone diameter is a parameter that can be specified as part of an individual lens design.

• Rigid gas permeable (RGP) and scleral lenses: Unlike standard soft contact lenses, RGP and scleral lenses are individually designed and manufactured. Because of this, practitioners can specify the back optic zone diameter (BOZD) during the fitting process.  The chosen BOZD must be large enough to accommodate the patient’s pupil size and provide the desired visual outcome. At the same time, it must be balanced with the lens’s peripheral curve design to maintain an appropriate fit on the cornea. Increasing the BOZD requires compensatory adjustment to the lens’s base curve so that the lens continues to align properly with the corneal surface. See our Base Curve page for more information on how lens curvature affects fit.
• Orthokeratology (ortho-k) lenses: Orthokeratology lenses are worn overnight to temporarily reshape the cornea, allowing clear unaided vision during the day and supporting myopia management. These lenses create a treatment zone on the cornea, and the diameter of that zone plays an important role in visual performance. The relationship between treatment zone size and pupil size can influence how well vision remains clear in different lighting conditions. For this reason, treatment zone and optic zone dimensions are important considerations when designing ortho-k lenses, particularly for patients undergoing myopia management.

What is the Difference Between Optic Zone Diameter and Overall Lens Diameter?

Although both measurements are expressed in millimetres, they describe different features of a contact lens.

The overall lens diameter (DIA) measures the full width of the lens from edge to edge. In soft contact lenses, this value commonly falls between 13.8 mm and 14.5 mm. Overall lens diameter affects how the lens covers the cornea and limbus and contributes to overall lens stability.

The optic zone diameter (OZD) measures only the central vision-correcting area of the lens. This is the area through which vision correction is delivered.

Because the optic zone occupies only the centre of the lens, it is always smaller than the overall diameter. The remaining area consists of peripheral and transition zones that help support lens fit, comfort and tear exchange beneath the lens.

Both measurements are important. A lens needs sufficient overall diameter to sit stably on the eye and an optic zone large enough to cover the pupil under different lighting conditions.

For a fuller understanding of contact lens design, see our Base Curve page, which explains how the curvature of the lens works alongside diameter and optic zone parameters to influence fit and performance.

The post Optic Zone Diameter in Contact Lenses appeared first on Ocuco.

Base curve is one of the key measurements used when fitting contact lenses. It describes the curvature of the back surface of a contact lens and helps determine how the lens aligns with the cornea, the clear front surface of the eye. On a contact lens prescription, it is usually abbreviated as “BC” and recorded in millimetres.

Although it appears as a single number, base curve plays an important role in lens fit, comfort, vision quality and eye health. A lens must sit securely on the eye while still allowing appropriate movement and tear circulation. For this reason, an optometrist confirms the appropriate base curve during a professional contact lens fitting.  

How is Base Curve Determined?

An optometrist selects a suitable lens base curve during a contact lens fitting. The process begins with measuring the shape and curvature of the cornea, the clear front surface of the eye.

Two commonly used technologies may be used to obtain these measurements:

• Keratometer: It measures the curvature of the central cornea at its principal meridians. It provides a radius of curvature in millimetres and remains a standard tool for routine contact lens fittings.
• Corneal Topographer: It creates a detailed map of the front surface of the cornea. This technology provides more detailed information than keratometry alone and is especially useful for patients with irregular corneas, those with corneal conditions such as keratoconus, or individuals being fitted with specialty lenses, including rigid gas permeable or scleral lenses.

Using these measurements, the optometrist selects a trial lens and evaluates its on-eye fit. A slit-lamp examination allows the practitioner to assess lens position, centration, movement during blinking and overall stability. The wearer is also asked about comfort and vision. The final base curve recommendation is based on both the corneal measurements and the results of this on-eye assessment.

What Do Base Curve Numbers Mean?

Base curve values are expressed in millimetres and describe the radius of the lens’ back surface. The numbering system can seem counterintuitive. A lower base curve value represents a steeper lens curvature, while a higher value represents a flatter curvature. For example, a lens with a base curve of 8.4 mm is steeper than a lens with a base curve of 8.8 mm.

Most soft contact lenses are manufactured with base curves ranging from 8.3 mm to 9.0 mm, with 8.4 mm and 8.6 mm among the most commonly available options.

However, the base curve should never be viewed in isolation. Contact lens designs vary in material, diameter, edge profile, thickness and overall lens design. As a result, two lenses carrying the same base curve value can fit differently on the eye.

Because of these design differences, base curve measurements are not directly interchangeable between brands. When changing to a different lens type or manufacturer, a new contact lens fitting is required to confirm that the lens provides an appropriate fit.

What Happens if the Base Curve is Wrong?

A contact lens that does not fit correctly can affect comfort, vision and the health of the ocular surface.

• If the lens is too steep (base curve number too small for the eye): The lens can fit too tightly against the cornea and move less than intended. Reduced tear exchange beneath the lens can lead to discomfort, redness and decreased oxygen availability to the corneal surface. A persistently tight fit increases the risk of corneal swelling (oedema) or the development of corneal neovascularisation, where new blood vessels grow into the normally clear cornea.

• If the lens is too flat (base curve number too large for the eye): The lens can move excessively with each blink or fail to remain centred over the cornea. This can lead to fluctuating vision, awareness of the lens, irritation and discomfort. A loose-fitting lens is also more likely to become displaced or dislodge during daily activities.

For these reasons, contact lens wearers should not attempt to alter their base curve independently when ordering replacement lenses. If lenses become uncomfortable or vision quality changes, the safest approach is to arrange a contact lens fitting review with an optometrist. A professional assessment can determine whether the issue relates to base curve, lens design, prescription changes or another aspect of eye health.

The post Base Curve Contact Lenses appeared first on Ocuco.

Negative Relative Accommodation (NRA) is a clinical test that quantifies the amount of accommodation the eyes can relax while still maintaining a single, fused binocular image at near. Rather than isolating accommodation on its own, the test captures how the accommodative and vergence systems work together. NRA forms part of a wider binocular vision workup and is normally recorded together with positive relative accommodation (PRA).

How is Negative Relative Accommodation Measured?

The test is carried out binocularly at a fixed near distance of 40 cm, with the patient’s full refractive correction in place. Using a phoropter or trial frame, the examiner adds plus power in +0.25 D increments while the patient reads a near target, usually a line one size larger than the smallest print they can read comfortably.

Plus lenses continue to be added until the patient first reports sustained blur that they cannot clear. At this point, the cumulative plus power is noted as the NRA result, recorded in positive diopters (for instance, +2.00 D).

Because the test reflects the coupling between accommodation and vergence, it is always performed binocularly. NRA is generally taken immediately before or after the PRA measurement, as the two are assessed as a pair.

What is a Normal NRA Value?

For patients who are not yet presbyopic, the expected NRA range sits between +1.75 D and +2.50 D, averaging close to +2.00 D. Children tend to produce higher figures, consistent with their greater accommodative range.

Findings below +1.75 D fall into the reduced category. Findings above +2.50 D are also clinically significant and warrant further investigation.

What Do Abnormal NRA Results Indicate?

An NRA reading outside the expected range can point in one of two directions, each with its own clinical implications.

Reduced NRA (below +1.75 D)

When NRA is low, it shows the accommodative system is unable to relax accommodation fully while maintaining clear, single binocular vision. This pattern is associated with accommodative spasm or accommodative excess, where the ciliary muscle stays contracted and has trouble letting go. Symptoms patients may report include:

• Distance vision that stays blurred after extended near tasks

• Trouble bringing distance objects into focus after time spent on a screen or book

• Pseudomyopia, where sustained accommodative contraction creates a temporary appearance of short-sightedness

Elevated NRA (above +2.50 D)

When NRA is elevated, it often points to a distance prescription carrying more minus power than the patient requires. To see clearly, the patient maintains a higher level of accommodative effort, and that baseline effort increases the recorded NRA value.

An NRA that comes in higher than expected should trigger a second look at the distance refraction. Uncorrected or under-corrected hyperopia can also produce an elevated NRA.

The post Negative Relative Accommodation (NRA) appeared first on Ocuco.

The National Health Service (NHS) is the publicly funded healthcare system that provides healthcare services to people across the United Kingdom. Founded on 5 July 1948, the NHS was created to ensure healthcare was available to everyone based on need rather than ability to pay. Today, it remains one of the largest publicly funded healthcare systems in the world. The NHS provides a wide range of services including primary care, hospital treatment, emergency care, mental health services, and community healthcare.

While the NHS is often referred to as a single organisation, it is actually made up of four separate healthcare systems serving England, Scotland, Wales, and Northern Ireland.

How is the NHS Funded?

The NHS is primarily funded through general taxation, with additional contributions from National Insurance. It operates as a single-payer system, meaning the government acts as the primary purchaser of healthcare services on behalf of the population.  

For the most part, using NHS services costs nothing at the point of use. Seeing a General Practitioner (GP), getting treated in an NHS hospital, receiving emergency care, and accessing most community health services typically don’t require any payment from patients.

That said, certain services in England do carry fees:

• Charges for NHS prescriptions
• Fees for NHS dental care
• NHS optical care for people who do not meet the relevant eligibility criteria

Because health policy is devolved to each UK nation, approaches vary. NHS prescriptions are free in Scotland, Wales, and Northern Ireland.

How is the NHS Structured?

ather than being one unified body, the NHS is really an umbrella term covering four separately run, publicly funded healthcare systems across the UK:

• NHS England: the largest system, serving the population of England
• NHS Scotland: operating under the Scottish Government
• NHS Wales (also known as GIG Cymru): operating under the Welsh Government
• Health and Social Care (HSC): Northern Ireland’s equivalent system
  

Each of these operates with its own leadership structure, spending priorities, and policy decisions; which means eligibility rules, charges, and the services on offer can vary quite a bit depending on which part of the UK you’re in.

Care in England is organized into two broad tiers, primary and secondary care. 

Primary care is where most patients first connect with the health system, delivered by:

• Family doctors (GPs)
• Optometrists
• Dentists
• Pharmacists based in the community

Secondary care includes hospital and specialist services, such as consultant appointments, surgery, diagnostic scans and specialised treatments. Patients usually need a referral from a primary care clinician to access these services.

How Do Patients Access NHS Services?

Primary care is the first point of contact for most patients in England. Registering with a GP practice is the main route into the NHS for most people. From there, GPs can evaluate, diagnose, and treat a broad range of conditions themselves, or refer patients on to specialists when needed.

Beyond GPs, people can also tap into NHS-funded care through:

• NHS Dentists  
• Pharmacies in their community
• Optometrists; free NHS sight tests are available to people who meet age, medical, sight-loss or low-income eligibility criteria

To reach secondary care—hospital treatment or specialist appointments—patients normally need a referral, which could come from a GP, dentist, optometrist, or another health professional.

For urgent or emergency situations, there are several routes:

• Calling 999 when a life is at risk
• Using NHS 111for urgent medical help or advice when the situation is not life-threatening
• Going to Accident and Emergency (A&E) for serious injuries or illnesses needing immediate care

Entitlement to free NHS hospital treatment is generally based on ordinary residence in the UK, not on nationality or National Insurance contributions. Overseas visitors may be charged for certain services, although exemptions apply. Eligibility and charging rules vary between the four UK nations.

The post National Health Service (NHS) appeared first on Ocuco.

A patient’s medical information has often traditionally been stored on paper — handwritten notes, physical test results, and paper charts filed within a single practice. An electronic medical record (EMR) is the digital equivalent of that paper chart. It holds the same core clinical information in a structured, searchable format, accessible to authorised staff within that organisation. EMRs are in use across both primary and secondary care, from GP practices to outpatient clinics and specialist services (in UK secondary care, the term electronic patient record (EPR) is also commonly used).

What Does an Electronic Medical Record Contain?

An EMR captures the clinical information generated within a single practice or healthcare organisation. Rather than a folder of paper notes, clinicians work with a digital record that consolidates patient data in one place. The contents of a standard EMR typically include:

• Patient demographics and contact details
• Medical history, covering past diagnoses and conditions
• Current medications and allergy records
• Consultation and examination notes recorded by clinical staff
• Test results and investigations requested within the practice
• Treatment plans and any referrals made

What appears in a given EMR will depend on the clinical setting and the software platform the organisation uses. One important boundary applies regardless of system: an EMR holds only the records created within that practice. Data from hospitals, other GP surgeries, or external laboratories does not automatically feed into it unless it is shared or imported through agreed connections or workflows.

What is the Difference Between an EMR and an EHR?

Although the two terms are used interchangeably in many contexts, EMR and EHR describe different things. The core difference is one of scope and how easily information is designed to be shared beyond a single organisation.

An EMR functions at the level of a single organisation. It records and stores clinical information generated there but is typically not designed to be shared outside the organisation. An EHR is built for interoperability: the intention is that information travels with the patient, giving different providers a joined-up view of their health history.

Within the UK, a third term is also in common use: electronic patient record (EPR). This is a commonly used term in secondary care, particularly across NHS trusts. In practice, the boundaries between all three terms are blurred, and a number of systems marketed as EMRs include interoperability features that bring them closer to EHR functionality.

How Are Electronic Medical Records Used in Clinical Practice?

Day-to-day, an EMR sits at the centre of how a practice operates. Clinical and administrative staff use it continuously across a working day for a broad range of functions:

• Documenting consultations and clinical findings as appointments take place
• Issuing and managing prescriptions, with often automated checks for drug interactions and allergy conflicts
• Ordering investigations and monitoring results returned to the practice
• Supporting appointment scheduling and patient recall, including reviews for long-term conditions and routine screening
• Producing referral letters and clinical correspondence directed to secondary care and other services

Practices operating EMR systems are bound by UK GDPR and the Data Protection Act 2018. This places clear obligations on them: records must be accurate, held securely, and made available only to staff with appropriate authorisation. Patients are entitled to request a copy of their own records at any time, a process handled through a subject access request (SAR), which can be made verbally or in writing, submitted directly to the practice.

The post Electronic Medical Record (EMR) appeared first on Ocuco.

Astigmatism is a common refractive error that causes blurred or distorted vision. It occurs when the front surface of the eye (the cornea) or, less commonly, the lens inside the eye is not perfectly round. Instead of having the same curvature in all directions, one meridian is steeper than the other.

As a result, light entering the eye does not focus on a single sharp point on the retina. Instead, it may focus on more than one plane, which can make vision appear blurred at near, far, or both distances. Astigmatism can occur on its own or alongside other refractive errors such as myopia (shortsightedness) or hyperopia (longsightedness).

What Causes Astigmatism?

Astigmatism is often described as two broad categories.

• Regular Astigmatism: In regular astigmatism, the most common form, the two principal meridians sit at right angles to one another. This predictable pattern means the condition responds well to correction through spectacles, toric contact lenses, or refractive surgery.

• Irregular Astigmatism: Here, the principal meridians are not perpendicular, and the corneal surface curves unevenly across multiple directions. Keratoconus, corneal scarring, prior eye surgery, and eye trauma are common underlying causes.

Because the optical distortion is less uniform, standard spectacles often fall short. Rigid gas permeable (RGP) or scleral contact lenses tend to deliver better outcomes, as they establish a smooth, consistent refracting surface across the cornea.

How is Astigmatism Corrected?

The right approach depends on the type and severity of astigmatism, the patient’s prescription, and their day-to-day requirements.

• Spectacles: The most widely used solution for regular astigmatism. Cylindrical or toric lenses compensate for the cornea’s uneven curvature, directing light more accurately onto the retina.

• Contact Lenses: Toric soft lenses are the most common prescription for regular astigmatism, engineered to hold a fixed orientation on the eye and maintain consistent correction. For irregular astigmatism, Rigid Gas Permeable (RGP) or scleral lenses are typically preferred. By forming a new optical surface over the cornea, they can achieve clarity that spectacles alone often cannot fully provide.

• Refractive Surgery: LASIK and PRK reshape the cornea directly, potentially eliminating (or significantly reducing) astigmatism and lessening reliance on corrective eyewear.

Candidacy isn’t universal. Suitability is assessed against factors such as astigmatism type and degree, corneal thickness, general eye health, and prescription stability, all evaluated through a thorough eye examination.

The post Astigmatism appeared first on Ocuco.

General Ophthalmic Services (GOS) is the NHS framework under which sight tests and optical vouchers are funded for eligible patients in the UK (with arrangements administered separately in each nation). It forms part of primary care and is delivered through contracted optometrists and optical practices acting on behalf of NHS England, and the corresponding bodies in Scotland, Wales, and Northern Ireland. 

Once a practice holds a GOS contract and the optometrist meets the relevant national registration requirements (for example, inclusion on the Ophthalmic Performers List in England), its optometrists can carry out NHS-funded eye examinations and provide optical vouchers to qualifying patients. Practices may also offer private services alongside NHS-funded care.

What Does GOS Cover?

GOS covers three core services, delivered by contracted optometrists and optical practices on behalf of the NHS:

• NHS sight tests (GOS1): a full eye examination for eligible patients, including checks on visual acuity, refraction, and the health of the eye.
• Optical vouchers (GOS3): provided to eligible patients to help cover the cost of spectacles or contact lenses, for patients who meet the NHS optical voucher eligibility criteria.
• Domiciliary sight tests: sight tests delivered in a patient’s home or care setting, for those unable to attend a practice in person (for example, at home, in a residential/care home, or at a day centre, depending on eligibility and circumstance).

Anything beyond the standard GOS sight test protocol, such as repeat visual fields testing or extended tonometry, sits outside GOS and can be offered as a private service.

Who is Eligible for GOS?

NHS-funded sight tests are available to patients who satisfy eligibility criteria set out by NHS England. Eligible groups include:

• Children under 16, or 16, 17 or 18 and in full-time education
• Adults aged 60 and over
• People diagnosed with diabetes or glaucoma
• People at risk of glaucoma (first-degree relatives of a glaucoma patient, aged 40 or over)
• People registered as sight impaired or severely sight impaired
• Holders of an NHS Low Income Scheme (HC2) certificate
• Prisoners and people in NHS-contracted care

Optical vouchers are subject to their own related eligibility rules. Eligibility for an optical voucher is not the same as eligibility for a free sight test, and criteria can vary across the UK. In England, NHS optical voucher eligibility is set out separately from NHS sight test eligibility.

How Does the GOS Contract Work for Optical Practices?

To deliver NHS-funded services, an optical practice needs a GOS contract with NHS England, or with the appropriate devolved authority in Scotland, Wales, or Northern Ireland. Contracts are tied to a specific practice location, so a business running several sites must hold a separate contract for each one.

In England, holding a GOS contract and performing GOS are not the same thing. Each optometrist (or ophthalmic medical practitioner) who performs NHS sight tests must be included on the Ophthalmic Performers List. A standard GOS contract does not automatically cover every service: in England, domiciliary (mobile) sight testing is provided under an “additional services” GOS contract, which is separate from the “mandatory services” contract for fixed premises.

Administration of GOS differs across the four UK nations, and eligibility and service scope vary as a result. In Scotland, NHS eye examinations are free for people who usually live in the UK (and certain other groups, such as refugees and asylum seekers). In Wales, free NHS-funded eye tests are available to people who meet the WGOS eligibility criteria (it is not a universal entitlement for all residents)

The post General Ophthalmic Services (GOS) appeared first on Ocuco.

An afferent pupillary defect (APD) is an abnormal pupil response caused by reduced afferent (sensory) input from the retina and optic nerve to the brain’s pupillary light reflex pathway. In day-to-day eyecare, the finding most commonly discussed is a relative afferent pupillary defect (RAPD), also called a Marcus Gunn pupil, which means one eye is providing a weaker light signal than the other eye.

In a normal pupil light reflex, shining light into one eye causes both pupils to constrict (a direct response in the illuminated eye and a consensual response in the other eye). With a RAPD, when the light is moved from the healthier eye to the affected eye, both pupils constrict less and may appear to dilate (“paradoxical dilation”) because the brain is receiving less afferent input from that eye than it received a moment earlier.

A RAPD is a clinical sign, not a diagnosis. It most often indicates unilateral or asymmetric disease affecting the optic nerve or retina, and it is detected during a routine pupil assessment using the swinging flashlight (swinging light) test.

What is the Difference Between an APD and a RAPD?

An afferent pupillary defect (APD) is a general term for a problem in the afferent (sensory) input to the pupillary light reflex. A relative afferent pupillary defect (RAPD) (also written rAPD) is the clinical finding that occurs when afferent input is unequal between the two eyes. RAPD is detected by comparing responses during the swinging flashlight test: when the light is moved from the less affected eye to the more affected eye, both pupils constrict less and may appear to dilate because the afferent signal is weaker from that eye.

In published writing, APD is sometimes used as shorthand for this relative finding, but RAPD is the more precise term for the typical bedside sign because it is defined by an inter‑eye difference.

How is an Afferent Pupillary Defect Detected?

An afferent pupillary defect is detected using the swinging flashlight test, a quick, non-invasive assessment performed as part of a routine pupil examination.

The test is carried out by first dimming the room and asking the patient to fixate on a distant target. A bright light is then directed into one eye for approximately three seconds. In a healthy visual system, both pupils constrict equally because the afferent signal from the illuminated eye triggers a bilateral pupillary response.

The eyecare professional (ECP) then swings the light to the fellow eye. If both eyes are functioning normally, the pupils remain constricted because the level of perceived light entering the visual system remains unchanged.

A positive RAPD is present when the pupils dilate rather than remain constricted as the light is moved to one eye, despite that eye being directly illuminated. This apparent paradox occurs because the affected eye is sending a weaker signal to the brain than the fellow eye. When the light is transferred to the affected eye, the brain interprets the change as a reduction in overall light intensity and responds by dilating both pupils.

The magnitude of the RAPD can also be graded using neutral density filters, allowing clinicians to monitor disease severity and progression over time.

What Causes an Afferent Pupillary Defect?

A positive RAPD indicates unilateral or asymmetric disease affecting the retina or optic nerve and most often reflects pathology in the prechiasmal afferent visual pathway (retina/optic nerve). Less commonly, asymmetric lesions involving the optic chiasm, optic tract, or midbrain pretectal region can also produce a RAPD. The defect reflects reduced afferent sensory input from one eye compared with the other.

Common causes include:

• Optic neuritis, an inflammatory condition of the optic nerve that is frequently associated with multiple sclerosis.
• Ischaemic optic neuropathy, which occurs when blood flow to the optic nerve is reduced.
• Glaucoma when optic nerve damage is significantly more advanced in one eye than the other.
• Severe retinal disease, including retinal detachment, central retinal artery occlusion, and central retinal vein occlusion.
• Optic nerve compression caused by conditions such as orbital tumours or thyroid eye disease.

Importantly, media opacities such as cataracts and corneal scarring do not cause a RAPD, provided the retina and optic nerve remain healthy. However, dense cataract has been reported to produce an apparent or contralateral RAPD through optical effects (for example, light scatter and altered retinal illumination), so a RAPD should not automatically be attributed to media opacity without considering retinal or optic nerve disease. This distinction is clinically useful because it helps differentiate reduced vision caused by refractive or media-related problems from vision loss resulting from retinal or neurological disease.

A positive RAPD is one of the most important objective signs of unilateral or asymmetric optic nerve and retinal disease. Because the test evaluates the integrity of the afferent visual pathway, it can reveal pathology even when visual acuity, colour vision, or fundus findings are only mildly affected.

The significance of a RAPD depends on the underlying cause. Conditions such as optic neuritis, ischaemic optic neuropathy, retinal artery occlusion, and compressive optic neuropathy can require urgent investigation, imaging, or referral to an ophthalmologist or neuro-ophthalmologist.

When a RAPD is detected, it is recommended to perform additional assessments, which may include visual acuity testing, colour vision testing, visual field assessment, retinal examination, optical coherence tomography (OCT), and neuroimaging where indicated. Identifying the cause promptly is important because some conditions can threaten vision permanently if left untreated.

The post Afferent Pupillary Defect appeared first on Ocuco.

Visual acuity (VA) refers to the ability of the visual system to resolve spatial detail As defined by the College of Optometrists. VA is a core clinical assessment. It quantifies how well the eye can distinguish and resolve minute spatial details, typically the smallest characters or symbols visible at a set distance. This measurement provides insight into both the refractive state of the eye and the functional integrity of the neural pathway carrying visual information from the retina to the cerebral cortex. Yet it is crucial to recognise that VA captures only one dimension of visual function. A complete picture of a patient’s sight requires interpreting VA results alongside their broader clinical context.  

What Does Visual Acuity Actually Measure?

At its core, visual acuity assesses the eye’s capacity to differentiate fine detail in controlled circumstances: high-contrast environments with standardised testing conditions. The test is centred on foveal (central) vision because the fovea(the anatomically specialised area at the centre of the macula)  is where cone cell density is greatest and where visual sharpness peaks.

Three interrelated systems must function together to produce normal acuity. The eye’s refractive apparatus —, chiefly the cornea and lens, must possess sufficient optical power to project a sharp image onto the retinal surface. The retina itself and the optic nerve must be structurally and functionally intact, enabling them to capture light signals and transmit them along the visual pathway. Finally, the brain’s visual cortex and associated processing centres must be able to interpret the incoming signals. Any disruption in any of these three systems, will degrade acuity. Causes include refractive defocus, media clouding, retinal degeneration, optic nerve disease, or brain-based visual processing impairment.

What Are the Types of Visual Acuity?

Visual acuity is assessed in different ways depending on the clinical need and the viewing distance.

Distance visual acuity (DVA) refers to the clarity with which fine detail can be resolved when viewed from 6 metres (20 feet) or more. This is the standard acuity measurement recorded in most optometry consultations and the type patients typically think of when undergoing a sight test. It reflects the visual demands of everyday distance tasks, such as recognising faces and reading signs.

Near visual acuity captures how well detail is resolved at close working distance, customarily set at 33-40 cm. Assessment of near acuity is especially important when evaluating presbyopia, investigating reading difficulties, and tracking changes in conditions that selectively impair vision at near distances, such as certain macular pathologies.

Presenting acuity is the acuity measured in the refractive state the patient currently habituates: with their spectacles on, their contact lenses in, following refractive surgery, or without any optical correction. This figure reflects the patient’s real-world visual experience outside the examination room.

Best-corrected visual acuity (BCVA) denotes the acuity threshold achieved when the patient wears or is fitted with the optically ideal refractive prescription. BCVA serves to parse out how much acuity loss stems from uncorrected refractive error versus how much arises from disease or structural damage that glasses alone cannot ameliorate.

What Visual Acuity Does Not Measure

VA testing measures central detail resolution under standardised, high-contrast laboratory conditions. It omits assessment of numerous other critical visual competencies:

• Visual field:  VA does not assess the extent of peripheral vision.   A person’s acuity score can remain at 6/6 or better whilst they experience substantial loss of peripheral vision. In primary open-angle glaucoma, peripheral vision is often affected first, while visual acuity is maintained until later in the disease.
• Contrast sensitivity: The ability to perceive subtle differences in luminance and to detect objects in low-contrast settings is independent of VA. Challenges with twilight driving, recognising worn text, or moving through dim environments often reflect compromised contrast sensitivity rather than reduced acuity. Standard acuity testing tells us nothing about this function.
• Colour vision: Recognition and discrimination of hues and wavelengths is not evaluated through standard VA testing. Colour vision is evaluated with separate tests.
• Binocular function: Although VA testing records each eye’s individual sharpness, it does not address how the eyes coordinate. Binocular vision includes eye alignment, vergence, and depth perception (stereopsis), which are assessed separately.

A complete examination systematically evaluates each of these visual components in isolation. Acuity reduction is merely one clinical observation among many; in itself, it cannot characterise a patient’s functional sight or visual quality of life.

What Causes Reduced Visual Acuity?

Acuity loss divides into two broad categories, and recognising which applies to each patient is essential to optometric assessment:

• Refractive error: The trio of myopia, hyperopia, and astigmatism all suppress acuity when left uncorrected. Uncorrected refractive error is the leading preventable cause of reduced presenting acuity and is readily treatable through spectacles, contact lenses, or surgical intervention. When presenting acuity shows marked improvement with refraction or trial lenses, a refractive cause is strongly suggested. Applying the optimal prescription typically restores the patient’s BCVA to normal or near-normal levels.

• Pathological causes: Opacification or dysfunction in the light-transmitting media (corneal scarring, cataracts, vitreous haemorrhage), compromise of retinal structure or photoreceptor function, optic nerve pathology, or disruption of the central visual pathways all have the capacity to lower best-corrected acuity. Typical examples range from cataract and age-related macular degeneration to diabetic retinopathy, amblyopia, optic neuritis, and rhegmatogenous retinal detachment. If acuity remains reduced despite optimal refractive correction, further investigation is required to identify or exclude underlying disease.

The post Visual Acuity appeared first on Ocuco.

Near Point of Convergence (NPC) is the closest distance from a person’s face at which their two eyes can still work together to keep a single, focused image before one eye loses its lock and vision splits into two.

It’s a simple test that tells clinicians how well a patient’s two eyes work together at close range. This measurement is a key part of any binocular vision assessment. It’s especially useful for patients reporting eyestrain, headaches, or difficulty reading.

How is Near Point of Convergence Measured?

The test involves moving a small target slowly along the midline towards the patient’s nose and watching carefully for two things.

The first is the break point: the moment at which the eyes can no longer hold fusion together and one eye deviates outward, or the patient reports seeing double. The second is the recovery point: the target is drawn back until the patient re-establishes single vision, which tells the clinician how readily the convergence system can reassert itself once it has failed.

In UK optometric practice, the standard tool for recording both values is the RAF rule (Royal Air Force near point rule), a calibrated rod that provides a standardised scale for measuring the distances in centimetres.

What the patient is asked to look at makes a meaningful difference to the outcome. Routine testing typically uses an accommodative target such as small print, which engages both the focusing and convergence systems simultaneously. When the aim is specifically to identify convergence insufficiency, a penlight paired with red-green glasses is more sensitive. It strips away the accommodative stimulus and tests the vergence system in isolation, often revealing a receded NPC that a standard target might miss.

Repeating the test increases its diagnostic sensitivity, since NPC values can shift with fatigue over successive attempts. A noticeably wider gap between an early and later reading can itself point to a problem.

What is a Normal NPC Value?

Clinically, a break point of 6 cm or less from the nose is generally considered normal, with a recovery point of 7 cm or less. These figures may vary depending on the patient’s age and the target used during testing, but a patient whose results fall within the expected range is generally considered to have adequate convergence for everyday near tasks.

In practice, several factors shift the figures. Older patients tend to show less robust convergence than younger ones, and results obtained with a penlight will often differ from those taken with a printed accommodative target. Neither variation is inherently problematic, but it underlines why the target type must always be noted alongside the measurement; without that context, the numbers are difficult to interpret or compare meaningfully over time.

A break point greater than around 10 cm is commonly used in clinical practice as one indicator of a receded NPC, though cited thresholds vary across the literature depending on the target used, and this should prompt further assessment.

What Does a Receded Near Point of Convergence Mean?

When the break point sits further from the nose than it should, the most likely explanation is convergence insufficiency (CI), a condition in which the eyes cannot sustain the inward effort required for comfortable near vision. It is the defining clinical sign of CI and the starting point for any investigation into the condition.

Patients with convergence insufficiency commonly report the following complaints:

• Headaches and eyestrain that build during reading, writing, or screen use
• Intermittent blurring or doubling of near text, particularly as concentration wanes
• A sense that words are shifting or unstable on the page
• Difficulty maintaining focus on near tasks, or losing their place repeatedly when reading

That said, a receded NPC does not confirm CI on its own. The full picture matters: clinicians will also assess the near phoria, test the positive fusional vergence reserves, and weigh the patient’s reported symptoms before arriving at a diagnosis. The NPC measurement is a critical piece of that picture, but only one piece.

How is Receded NPC Managed?

There is no single protocol for managing a receded NPC. Management depends on symptom severity, patient age, and the wider binocular vision assessment.

Office-based vision therapy, delivered by a clinician and reinforced at home, is the best-supported treatment. A 2020 Cochrane review of CITT trial data found it more effective than pencil push-ups or home computer therapy, which despite being the most commonly prescribed options, performed no better than placebo in trials.

Base-in prism can be incorporated into a spectacle prescription to reduce convergence demand rather than train the system to work harder. Trial evidence found it no more effective than placebo in children, so it’s typically reserved for patients who can’t complete a therapy programme.

Referral becomes appropriate when the NPC is not improving as expected, the binocular vision picture is more complex, or an underlying cause beyond a straightforward convergence issue is suspected.

The post Near Point of Convergence (NPC) appeared first on Ocuco.